Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:cancer
|
| gptkbp:affiliatedWith |
gptkb:Oregon_Health_&_Science_University
|
| gptkbp:director |
gptkb:Brian_Druker
|
| gptkbp:establishedIn |
2008
|
| gptkbp:focusesOn |
gptkb:cancer
cancer prevention cancer research |
| gptkbp:foundedBy |
gptkb:Brian_Druker
|
| https://www.w3.org/2000/01/rdf-schema#label |
Knight Cancer Institute
|
| gptkbp:locatedIn |
gptkb:Portland,_Oregon
|
| gptkbp:namedAfter |
gptkb:Phil_Knight
|
| gptkbp:notableFor |
precision medicine
development of Gleevec |
| gptkbp:offers |
clinical trials
cancer education patient care |
| gptkbp:parentOrganization |
gptkb:Oregon_Health_&_Science_University
|
| gptkbp:partOf |
gptkb:OHSU_Health
|
| gptkbp:receivedDonationAmount |
$500 million
|
| gptkbp:receivedDonationFrom |
gptkb:Phil_Knight
|
| gptkbp:website |
https://www.ohsu.edu/knight-cancer-institute
|
| gptkbp:bfsParent |
gptkb:OHSU
|
| gptkbp:bfsLayer |
6
|